TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Merck Life Science Oy
Closing information (x1000 SEK)
| Closing information | 2016/12 | 2015/12 | 2014/12 |
| Turnover |
78,956
|
70,851
|
52,116 |
| Financial expenses |
10
|
9
|
38 |
| Earnings before taxes |
2,392
|
1,663
|
2,959 |
| Total assets |
19,899
|
17,019
|
16,405 |
| Current assets |
258
|
228
|
590 |
| Current liabilities |
6,821
|
6,349
|
6,661 |
| Equity capital |
13,068
|
10,661
|
9,734 |
| - share capital |
1,339
|
1,279
|
1,332 |
| Employees (average) | 8 | 7 |
Financial ratios
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Solvency |
65.7%
|
62.6%
|
59.3% |
| Turnover per employee | 9,870 | 7,445 | |
| Profit as a percentage of turnover |
3.0%
|
2.3%
|
5.7% |
| Return on assets (ROA) |
12.1%
|
9.8%
|
18.3% |
| Current ratio |
3.8%
|
3.6%
|
8.9% |
| Return on equity (ROE) |
18.3%
|
15.6%
|
30.4% |
| Change turnover |
4,755
|
20,819
|
2,512 |
| Change turnover % |
6%
|
42%
|
5% |
| Chg. No. of employees | -1 | ||
| Chg. No. of employees % | -13% |
Total value of public sale
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.